FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311024201> ?p ?o ?g. }

• W4311024201 endingPage "265" @default.
• W4311024201 startingPage "249" @default.
• W4311024201 abstract "Excessive daytime sleepiness (EDS) associated with narcolepsy or obstructive sleep apnea (OSA) can impair vigilance/attention. Solriamfetol, a dopamine/norepinephrine reuptake inhibitor, is approved to treat EDS associated with narcolepsy (75-150 mg/day) or OSA (37.5-150 mg/day). The analysis reported here explored the use of the Sleep, Activity, Fatigue, and Task Effectiveness (SAFTE) model (used in transport industries to model performance based on accumulated sleep and circadian variability) as a substitute for healthy controls using psychomotor vigilance task (PVT) data collected during clinical studies.Data were analyzed from two phase 2 studies of solriamfetol in adults with OSA (NCT02806895, EudraCT 2015-003930-28) or narcolepsy (NCT02806908, EudraCT 2015-003931-36). Participants were randomly assigned 1:1 to solriamfetol 150 mg/day (3 days) followed by 300 mg/day (4 days), or placebo (7 days), then crossed over to the other treatment. Actual task effectiveness scores were calculated from average PVT inverse reaction time (pre-dose; 2 h post-dose; 6 h post-dose). Actigraphy-derived sleep intervals were used in SAFTE to determine modeled healthy control task effectiveness scores.In participants with OSA (N = 31) on placebo or solriamfetol, actual and modeled healthy control task effectiveness did not differ at any time point. In participants with narcolepsy (N = 20) on placebo, actual task effectiveness at 2 h post-dose was lower than modeled healthy control task effectiveness (nominal P = 0.03), a difference not present with solriamfetol. There was no main effect of solriamfetol on actual or modeled healthy control task effectiveness across time points.This study represents a novel application of the SAFTE biomathematical model to approximate healthy controls in sleep disorder research and provides valuable lessons that may optimize future research. Future studies should perform a priori power analyses for model-tested outcomes and use sleep measures that capture sleep fragmentation characteristic of sleep disorders for sleep input (e.g., total sleep time rather than time in bed).NCT02806895, EudraCT 2015-003930-28: A Randomized, Double-Blind, Placebo-Controlled, Crossover On-Road Driving Study Assessing the Effect of JZP-110 on Driving Performance in Subjects With Excessive Sleepiness Due to Obstructive Sleep Apnea. NCT02806908, EudraCT 2015-003931-36: A Randomized, Double-Blind, Placebo-Controlled, Crossover On-Road Driving Study Assessing the Effect of JZP-110 on Driving Performance in Subjects With Excessive Sleepiness Due to Narcolepsy." @default.
• W4311024201 created "2022-12-22" @default.
• W4311024201 creator A5014442262 @default.
• W4311024201 creator A5024899439 @default.
• W4311024201 creator A5030348595 @default.
• W4311024201 creator A5041513850 @default.
• W4311024201 creator A5055320353 @default.
• W4311024201 creator A5056097944 @default.
• W4311024201 creator A5056324198 @default.
• W4311024201 creator A5059334004 @default.
• W4311024201 creator A5060962184 @default.
• W4311024201 creator A5064225184 @default.
• W4311024201 creator A5073056331 @default.
• W4311024201 creator A5074327692 @default.
• W4311024201 creator A5078465675 @default.
• W4311024201 creator A5085985235 @default.
• W4311024201 creator A5088784581 @default.
• W4311024201 creator A5089724403 @default.
• W4311024201 date "2022-12-10" @default.
• W4311024201 modified "2023-10-14" @default.
• W4311024201 title "Psychomotor Vigilance Performance in Participants with Excessive Daytime Sleepiness in Obstructive Sleep Apnea or Narcolepsy Compared with SAFTE-FAST Model Predictions" @default.
• W4311024201 cites W143922047 @default.
• W4311024201 cites W1566633486 @default.
• W4311024201 cites W1590781620 @default.
• W4311024201 cites W1596589439 @default.
• W4311024201 cites W1796448685 @default.
• W4311024201 cites W1812375793 @default.
• W4311024201 cites W1974690957 @default.
• W4311024201 cites W1989117071 @default.
• W4311024201 cites W2011013654 @default.
• W4311024201 cites W2011435303 @default.
• W4311024201 cites W2031960514 @default.
• W4311024201 cites W2058520951 @default.
• W4311024201 cites W2062996432 @default.
• W4311024201 cites W2065513803 @default.
• W4311024201 cites W2110552089 @default.
• W4311024201 cites W2120586681 @default.
• W4311024201 cites W2135859448 @default.
• W4311024201 cites W2143215421 @default.
• W4311024201 cites W2154020826 @default.
• W4311024201 cites W2163444871 @default.
• W4311024201 cites W2319050049 @default.
• W4311024201 cites W2415223548 @default.
• W4311024201 cites W2755454518 @default.
• W4311024201 cites W2791461627 @default.
• W4311024201 cites W2900579861 @default.
• W4311024201 cites W2905201451 @default.
• W4311024201 cites W2907012309 @default.
• W4311024201 cites W2914272431 @default.
• W4311024201 cites W2950191476 @default.
• W4311024201 cites W2969387942 @default.
• W4311024201 cites W2988862114 @default.
• W4311024201 cites W2994299062 @default.
• W4311024201 cites W3013363791 @default.
• W4311024201 cites W3023512414 @default.
• W4311024201 cites W3091581051 @default.
• W4311024201 cites W3143524146 @default.
• W4311024201 cites W3163692037 @default.
• W4311024201 cites W4281763983 @default.
• W4311024201 cites W4297901983 @default.
• W4311024201 cites W4309862188 @default.
• W4311024201 cites W651011686 @default.
• W4311024201 cites W78749887 @default.
• W4311024201 doi "https://doi.org/10.1007/s40120-022-00425-w" @default.
• W4311024201 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36494591" @default.
• W4311024201 hasPublicationYear "2022" @default.
• W4311024201 type Work @default.
• W4311024201 citedByCount "0" @default.
• W4311024201 crossrefType "journal-article" @default.
• W4311024201 hasAuthorship W4311024201A5014442262 @default.
• W4311024201 hasAuthorship W4311024201A5024899439 @default.
• W4311024201 hasAuthorship W4311024201A5030348595 @default.
• W4311024201 hasAuthorship W4311024201A5041513850 @default.
• W4311024201 hasAuthorship W4311024201A5055320353 @default.
• W4311024201 hasAuthorship W4311024201A5056097944 @default.
• W4311024201 hasAuthorship W4311024201A5056324198 @default.
• W4311024201 hasAuthorship W4311024201A5059334004 @default.
• W4311024201 hasAuthorship W4311024201A5060962184 @default.
• W4311024201 hasAuthorship W4311024201A5064225184 @default.
• W4311024201 hasAuthorship W4311024201A5073056331 @default.
• W4311024201 hasAuthorship W4311024201A5074327692 @default.
• W4311024201 hasAuthorship W4311024201A5078465675 @default.
• W4311024201 hasAuthorship W4311024201A5085985235 @default.
• W4311024201 hasAuthorship W4311024201A5088784581 @default.
• W4311024201 hasAuthorship W4311024201A5089724403 @default.
• W4311024201 hasBestOaLocation W43110242011 @default.
• W4311024201 hasConcept C118552586 @default.
• W4311024201 hasConcept C121446783 @default.
• W4311024201 hasConcept C126322002 @default.
• W4311024201 hasConcept C142724271 @default.
• W4311024201 hasConcept C1513209611 @default.
• W4311024201 hasConcept C15744967 @default.
• W4311024201 hasConcept C164953862 @default.
• W4311024201 hasConcept C169760540 @default.
• W4311024201 hasConcept C169900460 @default.
• W4311024201 hasConcept C1862650 @default.
• W4311024201 hasConcept C192769605 @default.
• W4311024201 hasConcept C200678441 @default.

• next